Literature DB >> 8817023

Elimination of tinnitus following hearing preservation surgery for acoustic neuromas.

P J Catalano1, K D Post.   

Abstract

Fifty-one consecutive patients undergoing hearing preservation surgery for acoustic neuromas were evaluated with regard to tinnitus and level of hearing. In 25 patients, hearing was not preserved. In this group, postoperative tinnitus was present in 8 of 13 patients who noted this symptom preoperatively. Four of the remaining 12 patients developed tinnitus following surgery. In 26 patients, useful hearing was preserved (speech reception threshold < 50 dB, speech discrimination score > 60%). Although 10 patients in this group complained of tinnitus preoperatively, only 4 patients noted it following surgery. None of the 16 remaining patients in this group developed tinnitus postoperatively. Overall, only 50% (12/23) of patients who had tinnitus preoperatively complained of it postoperatively, and only 8% (4/51) developed tinnitus as a result of surgery. Our results show that new-onset tinnitus is uncommon following hearing preservation surgery for acoustic neuroma and that it can be reduced or eliminated following surgery, especially if useful hearing is preserved.

Entities:  

Mesh:

Year:  1996        PMID: 8817023

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  3 in total

1.  Does hearing preservation surgery for acoustic neuromas affect tinnitus?

Authors:  J Kanzaki; A Satoh; T Kunihiro
Journal:  Skull Base Surg       Date:  1999

2.  Does attempt at hearing preservation microsurgery of vestibular schwannoma affect postoperative tinnitus?

Authors:  Martin Chovanec; Eduard Zvěřina; Oliver Profant; Zuzana Balogová; Jan Kluh; Josef Syka; Jiří Lisý; Ilja Merunka; Jiří Skřivan; Jan Betka
Journal:  Biomed Res Int       Date:  2015-01-12       Impact factor: 3.411

3.  Postoperative Tinnitus After Vestibular Schwannoma Surgery Depends on Preoperative Tinnitus and Both Pre- and Postoperative Hearing Function.

Authors:  Leonidas Trakolis; Florian H Ebner; Kathrin Machetanz; Joey Sandritter; Marcos Tatagiba; Georgios Naros
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.